Actively Recruiting

Age: 18Years +
FEMALE
NCT05051722

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Led by Mayo Clinic · Updated on 2026-04-17

3110

Participants Needed

24

Research Sites

308 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The overarching objective of this project is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer-specific methylated DNA markers and high-risk human papilloma virus (HR-HPV) detected in vaginal fluid and/or plasma. This proposal defines Phase II MDM-based cancer detection studies in endometrial cancer (EC) and endometrial hyperplasia with atypia (AEH) in vaginal fluid and 2) ovarian cancer (OC) in plasma and vaginal fluid. Additionally, it defines necessary Phase I MDM-based cancer detection and exploratory aims to test novel cervical cancer (CC) MDMs and test the specificity of cancer-specific MDMs among various common benign gynecologic pathologies.er detection and exploratory aims to test novel cervical cancer MDMs and test the specificity of cancer-specific MDMs among various common benign gynecologic pathologies.

CONDITIONS

Official Title

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 45 years or older with abnormal uterine bleeding or postmenopausal bleeding
  • Patients aged 18 to 44 years with abnormal uterine bleeding plus one risk factor for endometrial cancer (BMI 30 or higher, PCOS, or Tamoxifen use)
  • Patients aged 18 years or older with biopsy-proven endometrial cancer or atypical endometrial hyperplasia with planned surgical intervention
  • Patients aged 18 years or older with a cervix and abnormal cervical/endocervical Pap test, cervical mass, or planned cervical surgical biopsy/removal
  • Patients aged 45 years or older undergoing hysterectomy or gynecologic surgery for benign uterine or gynecologic conditions such as fibroids, endometriosis, adenomyosis, or benign endometrial polyps
  • Patients aged 45 years or older presenting for gynecologic wellness exam with no recent changes in medical conditions or medications
  • Patients aged 50 years or older who are postmenopausal with at least one intact ovary, diagnosed with or suspected of adnexal mass or early-stage ovarian cancer with planned surgery
  • Women aged 18 years or older with clinically probable ovarian, fallopian tube, or primary peritoneal cancer newly diagnosed without prior neoadjuvant therapy and at least one intact ovary
Not Eligible

You will not qualify if you...

  • Prior hysterectomy
  • Current known pregnancy
  • Prior pelvic or vaginal radiotherapy
  • Any cancer diagnosis (except basal cell skin cancer) within the past 5 years
  • Chemotherapy within the past 5 years
  • Current biopsy-proven cervical, vaginal, vulvar, or endometrial cancer or dysplasia
  • Current biopsy-proven benign endometrial polyp or biopsy showing benign endometrium within the past month
  • Prior intervention or surgery intended to completely remove the target pathology
  • Undergoing surgery for recurrent or metastatic endometrial or ovarian cancer
  • History of pelvic or vaginal radiation therapy
  • Surgical candidates for recurrent ovarian cancer
  • Clinically suspected advanced stage ovarian cancer (Stage III or IV)
  • Pap test or cervical biopsy within the past month
  • Endometrial biopsy or hysteroscopy within 1 to 2 weeks or 1 month depending on cohort
  • Surgery within the past 3 months
  • Patients presenting for colposcopy for surveillance without current abnormalities
  • Known synchronous endometrial cancer or hyperplasia with ovarian cancer
  • Known cervical, vaginal, or vulvar dysplasia or cancer
  • Criteria met for inclusion in other study cohorts

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 24 locations

1

Mayo Clinic

Phoenix, Arizona, United States, 85054

Actively Recruiting

2

Mayo Clinic

Jacksonville, Florida, United States, 32224

Actively Recruiting

3

My GYN Care

Miami, Florida, United States, 33156

Active, Not Recruiting

4

Genoma Research, Inc.

Miami, Florida, United States, 33173

Actively Recruiting

5

Orlando Health

Orlando, Florida, United States, 32806

Actively Recruiting

6

Signature Women's Healthcare, LLC

Pembroke Pines, Florida, United States, 33029

Active, Not Recruiting

7

Sarasota Memorial Health Care System

Sarasota, Florida, United States, 34239

Actively Recruiting

8

Piedmont Healthcare

Atlanta, Georgia, United States, 30318

Actively Recruiting

9

University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

10

Providea Health Partners, LLC

Evergreen Park, Illinois, United States, 60805

Active, Not Recruiting

11

Ochsner Clinic Foundation

New Orleans, Louisiana, United States, 70121

Actively Recruiting

12

Valley OB-GYN Clinic

Saginaw, Michigan, United States, 48602

Actively Recruiting

13

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

14

University of Mississippi Medical Center

Jackson, Mississippi, United States, 39213

Actively Recruiting

15

The Woman's Health Pavilion

Howard Beach, New York, United States, 11414

Actively Recruiting

16

The Woman's Health Pavilion

Westbury, New York, United States, 11590

Actively Recruiting

17

Altru Health System

Grand Forks, North Dakota, United States, 58206

Actively Recruiting

18

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

19

Total Women's Care of the Heights

Houston, Texas, United States, 77018

Actively Recruiting

20

Medical Colleagues of Texas, LLP

Katy, Texas, United States, 77450

Actively Recruiting

21

Virginia Commonwealth University/ Massey Cancer Center

Richmond, Virginia, United States, 23219

Actively Recruiting

22

Mayo Clinic Health System - Northwest Wisconsin

Eau Claire, Wisconsin, United States, 54703

Actively Recruiting

23

Mayo Clinic Health System - Southwest Wisconsin

La Crosse, Wisconsin, United States, 54601

Actively Recruiting

24

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Active, Not Recruiting

Loading map...

Research Team

M

Maureen A Lemens, BSN

CONTACT

C

Clinical Trials Referral Office

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

7

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here